بنجامین، سادوک. ؛ سامون، احمد. ؛ و ویرجینیا سادوک. دستنامه روانپزشکی بالینی ویرایش ششم (2019). ترجمه: رضایی فرزین. تهران. انتشارات ارجمند.
Alexis, E. ; Whitton, Jenna M. ; Reinen, Mark. ; Slifstein, Yuen-Siang. ; Ang, Patrick .J. ; McGrath, DanV. ; Iosifescu, AnissaAbi-Dargham, DiegoA. & Pizzagalli, FranklinR Schneier (2020). »Baseline Reward Processing and Ventrostriatal Dopamine Function Are Associated With Pramipexole Response in Depression«.
BrainJournal of Neurology, Volume 143, Issue 2, Pages 701–710.
American Psychiatric Association (2014). Diagnostic and Statistical Manual of Mental Disorders DSM-5. American Psychiatric Association, Washington, DC.
Beck, AT. ; Ward, CH. ; Mendelson. ; M, Mock, J. & Erbaugh J (1961). »An inventory for measuring depression«. Arch Gen Psychiatry, 4: 561-571.
Beck, AT. ; Beck, R. & Kovacs, M (1975). Classification of suicidalbehaviors: I.Quantifying. Am«. J. Psychiatry, 132: 285-287.
Bowirrat, A. & Oscar-Berman, M (2005). »Relationship between dopaminergic neurotransmission, alcoholism, and reward deficiency syndrome«. Am. J. Med. Genet. B: Neuropsychiatr. Genet, 132B: 29–37.
Contreras, F. ; Fouillioux, C. ; Bolívar, A. ; Simonovis, N. ; Hernandez-Hernandez R. ; Armas-Hernandez M. & Velasco M (2002). »Dopamine, hypertension and obesity«. J Hum Hypertens, 16: 13–7.
Danna, C. L. & Elmer, G. I (2010). »Disruption of conditioned reward association by typical and atypical antipsychotics«. PharmacolBiochemBehav, 96: 40-47.
Dunlop, BW. & Nemeroff, CB (2007). »The role of dopamine in the pathophysiology of depression«. Arch Gen Psychiatry, 64: 327–337.
Fan, M. ; Liu, B. ; Jiang, T. ; Jiang, X. ; Zhao, H. & Zhang J (2010). »Meta-analysis of the association between the monoamine oxidase-A gene and mood disorders«. Psychiatry Genet, 20: 1-7.
Fitzgerald, PB. ; Laird, AR. ; Maller, J. & Daskalakis ZJ (2008). »A meta-analytic study of changes in brain activation in depression«. Hum Brain Mapp, 29: 683–695.
Flint, J. & Kendler, KS (2014). The Genetics of Major Depression neuron, 81:484-503.
G Zalsman, A. ; Frisch, R. ; Lewis, E.; Michaelovsky, H. ; Hermesh, L. ; Sher, E. ; Nahshoni, L. ; Wolovik, S. ; Tyano, A. ; Apter, R & Weizman, A (2004). »Weizman DRD4 receptor gene exon III polymorphism in inpatient suicidal adolescents«. Journal of Neural Transmission. Volume 111, pages, 1593–1603.
Gershon, A. A. ; Vishne, T. & Grunhaus L (2007). »Dopamine D2-like receptors and the antidepressant response«. Biol Psychiatry, 61: 145–153.
Hahn, T. ; Heinzel, S. ; Dresler, T. ; Plichta, MM. ; Renner, TJ. ; Markulin, F.& et al (2011). »Association between reward-related activation in the ventral striatum and trait reward sensitivity is moderated by dopamine transporter genotype«. Hum Brain Mapp, 32: 1557-1565.
Hamidovic, A. ; Dlugos, A. ; Skol,A. ; Palmer, A. A. & de-Wit H (2009). »Evaluation of genetic variability in the dopamine receptor D2 in relation to behavioral inhibition and impulsivity/sensation seeking: an exploratory study with d-amphetamine in healthy participants«. ExpClinPsychopharmacol, 17: 374-383.
Horvitz, J. C (2009). »Mesolimbocortical and nigrostriatal dopamine responses to salient non-reward events«. Neuroscience, 96: 651-656.
J, H. Lai. ; Y, S Zhu. ; Z, H. Huo. ; R, F. Sun. ; B, Yu. ; Y, P. Wang. ; Z, Q Chai. & S, B Li (2010). »Association study of polymorphisms in the promoter region of DRD4 with schizophrenia, depression, and heroin addiction«.
Brain Journal of Neurology 4, 1359:227-32.
Jonathan, F. & Kenneth, SK (2014). »The Genetics of Major Depression«. Neuron, 81: 484-503.
Josefsson, A. ; Vikstrom, J. ; Bladh, M. ; Sydsjo, G (2018). »Major depressive disorder in women and risk for future generations: population-based three-generation study«. BJPsych Open, 1-8.
Kobiella, A. ; Vollstadt-Klein, S. ; Buhler, M. ; Graf, C. ; Buchholz, H. G. ; Bernow N & et al (2010). »Human dopamine receptor D2/D3 availability predicts amygdala reactivity to unpleasant stimuli«. Hum Brain Mapp, 31: 716-726.
Koks, S. ; Nikopensius, T. ; Koido, K. ; Maron, E. ; Altmae, S. ; Heinaste, E. & et al (2006). »Analysis of SNP profiles in patients with major depressive disorder«. International JournalNeuropsychopharmacol, 9: 167–174.
Korhonen, T. ; Loukola, A. ; Wedenoja, J. ; Nyman, E. ; Latvala A. & et al (2014). »Role of Nicotine Dependence in the Association between the Dopamine Receptor Gene DRD3 and Major Depressive Disorder«. Plos one, 9(6): e98199.
Lammers, CH. ; Diaz, J. ; Schwartz JC. & Sokoloff, P (2000). »Selective increase of dopamine D3 receptor gene expression as a common effect of chronic antidepressant treatments«. Mol Psychiatry, 5: 378–388.
Levinson, DF (2006). »The genetics of depression: a review«. Biol Psychiatry, 60: 84-92.
Lopez-Leon, S. ; Croes, EA. ; Sayed-Tabatabaei, FA. ; Claes, S. ; Van Broeckhoven, C. & et al(2005). »The dopamine D4 receptor gene 48-base-pair-repeat polymorphism and mood disorders: a meta-analysis«. Biol Psychiatry, 57: 999–1003.
Lopez-Leon, S. ; Janssens, AC. ; Gonzalez-Zuloeta, LaddAM. ; Del-Favero, J. ;Claes, SJ. ; Oostra, BA. & et al (2008). »Meta-analyses of genetic studies on major depressive disorder«. Mol Psychiatry, 13: 772–785.
Marijeaanh, R. ; Sanjay, JM. & Dennis SC (2009). »Neurobiological mechanisms in major depressive disorder«. CMAJ, 180: 40-61.
Matsumoto, M. ; Hidaka, K. ; Tada, S. ; Tasaki, Y. & Yamaguchi, T (1995). »Full-length cDNA cloning and distribution of human dopamine D4 receptor«. MolBrain Res, 29: 157–162.
Mei, H. ; Hong, Y. ; Zhao-Xia, D. ; Wei, Q. ; Hai-Yan, G. ; Zheng-Li, F. & et al (2013). »Genetic distribution and association analysis of DRD2 gene polymorphisms with major depressive disorder in the Chinese Han population«. Internatoinal Journal Clin Exp Pathol, 6:1142-1149.
Mizrahi, R. ; Rusjan, P. ; Agid, O. ; Graff, A. ; Mamo, DC. ; Zipursky RB. & Kapur S (2007). »Adverse subjective experience with antipsychotics and its relationship to striatal and extrastriatal D2 receptors: a PET study in schizophrenia«. Am J Psychiatry, 164: 630-637.
NCBI. DRD1 dopamine receptor D1 (2020). Homo sapiens (human). Gene ID: 1812, updated on 13-Jul.
NCBI. DRD2 dopamine receptor D2 (2020). Homo sapiens (human). Gene ID: 1813, updated on 13-Jul.
NCBI. DRD3 dopamine receptor D3 (2020). Homo sapiens (human). Gene ID: 1814, updated on 13-Jul.
NCBI. DRD4 dopamine receptor D4 (2020). Homo sapiens (human). Gene ID: 1815, updated on 13-Jul.
NCBI. DRD5 dopamine receptor D5 (2020). Homo sapiens (human)] Gene ID: 1816, updated on 13-Jul.
Nyman, ES. ; Sulkava, S. ; Soronen, P. ; Miettunen, J. ; Loukola, A. & et al (2011). »Interaction of early environment, gender and genes of monoamineneurotransmission in the aetiology of depression in a large population-based finnish birth cohort«. bmj open,1(1):1-13.
Roee, A. ; Roselinde, H. K. ; Daniel, G. D, Miranda, B. ; Franziska, G. ; David, P. O. ; Gordana, V. & Diego, A. P (2017). »Dopaminergic enhancement of striatal response to reward in major depression«. Am J Psychiatry, 174(4): 378–386.
Sullivan, PF. ; Neale, MC. ; Kendler. & KS (2000). »Genetic epidemiology of major depression: review and meta-analysis«. American Journal Psychiatry, 157: 1552–1562.
Szczypinski, J. J. &
Gola, M (2018). »Dopamine dysregulation hypothesis: the common basis for motivational anhedonia in major depressive disorder and schizophrenia?«.
Reviews Neurosciences. 25, 29(7): 727-744.
Talati, A. ; Weissman, M. M. &. Hamilton, SP (2013). »Using the high-risk family design to identify biomarkers for major depression«. Philosophical Transactions of the royal society, 368:1-10.
Tang, L. ; Todd, RD. ; Heller, A. & O’Malley KL (1994). »Pharmacological and functional characterization of D2, D3 and D4 dopamine receptors in fibroblast and dopaminergic cell lines«. J PharmacolExpTher, 268: 495–502.
Williams, LM. ; Gatt, JM. ; Grieve, SM. ;Dobson-Stone, C. ; Paul, RH. ; Gordon, E. & Schofield PR (2010). »COMT Val (108/158) Met polymorphism effects on emotional brain function and negativity bias«. Neuroimage, 53: 918-925.
Willner,P (1997). »The mesolimbic dopamine system as a target for rapid antidepressant action«. IntClinPsychopharmacol, 12 (Suppl 3): S7–S14.
Wong, AH. & Liu, F (2012). »Uncoupling the dopamine D1-D2 receptor complex: a novel target for antidepressant treatment«. ClinPharmacolTher, 91(2): 298-302.